Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
World J Gastroenterol ; 25(28): 3775-3786, 2019 Jul 28.
Article in English | MEDLINE | ID: mdl-31391772

ABSTRACT

BACKGROUND: Pancreatic cancer is a deadly malignancy with aggressive properties. MicroRNAs (miRNAs) participate in the pathogenesis of a variety of diseases and molecular processes by targeting functional mRNAs. Nevertheless, the regulatory role of miRNAs in signaling pathways involved in pancreatic cancer remains largely unknown. AIM: To explore the molecular regulation involved in pancreatic cancer and potential mechanisms of miR-205. METHODS: Microarray analysis was performed to investigate the expression profile of miRNAs in pancreatic cancer. Expression of miR-205 was validated by qRT-PCR. Target prediction and functional enrichment analysis were employed to seek potential target genes of miR-205 and potential functions of these genes. The target binding of miR-205 and adenomatous polyposis coli (APC) was validated by luciferase reporter assay. APC protein expression in pancreatic cancer was validated by qRT-PCR and Western blot. Proliferation was evaluated by MTT and colony formation assays. RESULTS: A large number of miRNAs with altered expression were identified in pancreatic cancer. MiR-205 was significantly up-regulated. APC was found to be a validated target of miR-205 and down-regulated in pancreatic cancer. Proliferation experiments showed that miR-205 could promote cell proliferation in pancreatic cancer by targeting APC. CONCLUSION: The above findings suggested that miR-205 mediated APC regulation contributes to pancreatic cancer development, which could be considered as a novel prognostic biomarker for clinical care.


Subject(s)
Adenomatous Polyposis Coli Protein/genetics , Biomarkers, Tumor/metabolism , Gene Expression Regulation, Neoplastic , MicroRNAs/metabolism , Pancreatic Neoplasms/genetics , Aged , Aged, 80 and over , Cell Proliferation/genetics , Down-Regulation , Female , Gene Expression Profiling , Humans , Male , Middle Aged , Oligonucleotide Array Sequence Analysis , Pancreas/pathology , Pancreatic Neoplasms/pathology , Primary Cell Culture , Prognosis , Tumor Cells, Cultured , Up-Regulation
2.
Br J Oral Maxillofac Surg ; 46(3): 192-197, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18164790

ABSTRACT

Our aim was to examine the change in expression of matrix metalloproteinases (MMP-13), matrix metalloproteinases-3 (MMP-3), and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in the articular cartilage of goats with experimentally-induced osteoarthrosis of the temporomandibular joint (TMJ) at various times. Osteoarthrosis was induced in 20 goats in the bilateral TMJ and 5 goats acted as controls. There were 5 goats in each group, and a group was killed at 7 days, and 1, 3, and 6 months postoperatively. The samples were collected, and the joints evaluated histologically. Immunofluorescence was used to detect the presence of MMPs and TIMP-1 in the articular disc and condylar cartilage. The ultrastructure of the articular disc and condylar surface at 1 month was examined with scanning electron microscopy (SEM). Osteoarthrosis of the TMJ progressed gradually over time. MMP-13, MMP-3, and TIMP-1 were expressed strongly in the TMJ soon after injury; MMP-13 became gradually weakened, and MMP-3 strengthened later. None of these were expressed in the normal condyle. After a month the surface of the arthrotic condyle was uneven, and the underlying collagen fibrils were exposed in irregular fissures on the surface. The secretion of TIMP-1 was related closely to the changes of MMPs during osteoarthrosis of the TMJ. The unbalanced ratio between them caused degradation of the matrix of the cartilage and might be the cause of osteoarthrosis of the TMJ.


Subject(s)
Matrix Metalloproteinase 13/analysis , Matrix Metalloproteinase 3/analysis , Osteoarthritis/enzymology , Temporomandibular Joint Disorders/enzymology , Tissue Inhibitor of Metalloproteinase-1/analysis , Animals , Cartilage, Articular/enzymology , Cattle , Goats , Male , Mandibular Condyle/ultrastructure , Rabbits , Surface Properties , Temporomandibular Joint/injuries , Temporomandibular Joint/ultrastructure , Temporomandibular Joint Disc/ultrastructure , Temporomandibular Joint Disorders/etiology , Time Factors
3.
Mol Cell Biochem ; 302(1-2): 233-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17415623

ABSTRACT

MyoD of the myogenic regulatory factors (MRFs) family regulates the skeletal muscle differentiation program. In this study, stably transfected NIH3T3-derived cell lines were established, in which exogenous MyoD was expressed at high levels. Transcriptional activation of endogenous muscle regulatory gene and induction towards the skeletal muscle lineages were observed with phase-contrast microscopy when continuously cultured in vitro. Moreover, to determine their ability of myogenic formation in vivo, the transfected cells were implanted in nude mice subcutaneously for up to 10 weeks. The morphological characterization of inductive cells was observed using transmission electron microscope and histological staining. Myogenesis of fibroblasts incubated in the medium was activated by overexpression of MyoD, and the cells were accumulated and fused into multinucleated myotubes. Correlatively, RT-PCR and immunohistochemistry confirmed the increased expression of characteristic downstream molecule myogenin and mysion heavy chains during myogenic differentiation. Ecoptic myogenesis was found and remained stable phenotype when the transfected cells were seeded in vivo. Our results suggest that MyoD can be considered to be a determining factor of myogenic lineages, and it may play an important role in the cell therapy and cell-mediated gene therapy of the skeletal muscle.


Subject(s)
Cell Differentiation , Fibroblasts/cytology , Muscle, Skeletal/cytology , MyoD Protein/metabolism , Animals , Gene Expression , Mice , Muscle Development , MyoD Protein/genetics , Myogenin/metabolism , Myosins/metabolism , NIH 3T3 Cells , Transfection
4.
Zhonghua Zheng Xing Wai Ke Za Zhi ; 20(5): 333-5, 2004 Sep.
Article in Chinese | MEDLINE | ID: mdl-15623097

ABSTRACT

OBJECTIVE: To evaluate a new technique to treat severe maxillofacial deformity and dysfunction of occlusion after the maxillofacial fractures. METHODS: Thirty-four consecutive patients, with delayed maxillofacial deformities and dysfunction of occlusion after the maxillofacial fractures, were treated by the use of x-ray cephalometric analysis, model surgery, open reduction and rigid internal fixation. RESULTS: Thirty-three patients were successfully corrected the maxillofacial deformities, facilitated normal occlusal relationship. Only one patient with severe damage of the brain was presented a mild occlusion dysfunction one year after the operation. CONCLUSIONS: The above-mentioned technique may be a viable and effective option for the management of the deformities of the face and dentition after the maxillofacial fractures.


Subject(s)
Maxillofacial Abnormalities/surgery , Orthopedic Procedures/methods , Adult , Aged , Female , Follow-Up Studies , Fracture Fixation/methods , Fracture Fixation, Internal/methods , Humans , Male , Maxillofacial Injuries/surgery , Middle Aged , Oral Surgical Procedures/methods , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...